Amine

Ascend to showcase clay control, scavenging technologies and additives at SPE HFTC

Retrieved on: 
Thursday, February 1, 2024
Convention center, Booth, Ascend, Society, Transport, Exhibition, Formaldehyde, Amine, SPE, Mineral oil, Conference, Fine chemical

The portfolio includes specialty chemicals – many produced in the Houston area and all made in the U.S.A. – designed to improve clay control, hydrogen sulfide scavenging, scale inhibition, and more.

Key Points: 
  • The portfolio includes specialty chemicals – many produced in the Houston area and all made in the U.S.A. – designed to improve clay control, hydrogen sulfide scavenging, scale inhibition, and more.
  • Hexatran™ Hexasalt is a cost-effective, semi-permanent clay stabilizer that outperforms common alternatives.
  • Amines such as FlexaTram™-BHM and FlexaTram™-HMT are additives in scale and corrosion inhibitors, frac sand coatings, and clay stabilizers.
  • Ascend is exhibiting at Booth 818 at the SPE HFTC February 6-8 at The Woodlands Waterway Marriott Hotel & Convention Center in The Woodlands, Texas.

Ascend to showcase clay control, scavenging technologies and additives at SPE HFTC

Retrieved on: 
Thursday, February 1, 2024
Convention center, Booth, Ascend, Society, Transport, Exhibition, Formaldehyde, Amine, SPE, Mineral oil, Conference, Fine chemical

The portfolio includes specialty chemicals – many produced in the Houston area and all made in the U.S.A. – designed to improve clay control, hydrogen sulfide scavenging, scale inhibition, and more.

Key Points: 
  • The portfolio includes specialty chemicals – many produced in the Houston area and all made in the U.S.A. – designed to improve clay control, hydrogen sulfide scavenging, scale inhibition, and more.
  • Hexatran™ Hexasalt is a cost-effective, semi-permanent clay stabilizer that outperforms common alternatives.
  • Amines such as FlexaTram™-BHM and FlexaTram™-HMT are additives in scale and corrosion inhibitors, frac sand coatings, and clay stabilizers.
  • Ascend is exhibiting at Booth 818 at the SPE HFTC February 6-8 at The Woodlands Waterway Marriott Hotel & Convention Center in The Woodlands, Texas.

Amino Health Announces John Asalone as New CEO; David Vivero Assumes Role of Chairman in CEO Succession

Retrieved on: 
Wednesday, December 13, 2023
Data Management, Technology, Professional Services, Managed Care, Health, Venture Capital, Health Technology, Health Insurance, Software, Hospitals, Internet, Emerge Commerce, GoodRx, SVP, Growth, Multimedia, Todd Asalon, Amine, Lead, Nursing, Fine chemical, Health insurance

Amino Health, the leading digital healthcare navigation company, today announced the appointment of John Asalone to the role of Chief Executive Officer.

Key Points: 
  • Amino Health, the leading digital healthcare navigation company, today announced the appointment of John Asalone to the role of Chief Executive Officer.
  • He succeeds David Vivero, the company's visionary founder and CEO, who steps into a new role as Chairman.
  • “I joined Amino to advance its mission of transforming how Americans engage with the healthcare system,” said Asalone.
  • Using Amino, members successfully find high-quality and appropriate providers three times more often than people without Amino.

NxGen Brands, Inc. Continues Explosive Entrance into Nutritional Supplement Market with Second Acquisition

Retrieved on: 
Thursday, December 7, 2023
Storm, DTC, Acquisition, Testosterone, Pre-workout, Marketing, Share (finance), Social media, Amine, Letter, Retail

DENVER, Dec. 7, 2023 /PRNewswire/ -- NxGen Brands, Inc. (OTCMKTS: NXGB) ("NxGen" or the "Company"), (www.nxgenbrands.com) signs letter of intent to acquire one of America's fastest growing Nutritional Supplement Brands.

Key Points: 
  • DENVER, Dec. 7, 2023 /PRNewswire/ -- NxGen Brands, Inc. (OTCMKTS: NXGB) ("NxGen" or the "Company"), ( www.nxgenbrands.com ) signs letter of intent to acquire one of America's fastest growing Nutritional Supplement Brands.
  • The acquisition target will likely have unaudited revenues of around $1m at closing for 2023 and is profitable.
  • This will be NxGen's second acquisition of the year.
  • Only 5.6 million are currently held at DTC in the free trading float and the Issued Share Capital is 63,079,566.

IDTechEx Analysis: Emerging Molecules Produced Through Industrial Biomanufacturing

Retrieved on: 
Tuesday, November 7, 2023
Polymer, SCFA, Nylon, Dicarboxylic acid, PHA, Textile, Polyester, Biomass, Spider, Polyhydroxyalkanoates, Chemical industry, Lubricant, Biotechnology, Digestion, United Nations, Caprolactam, Fermentation, Alcohol, Mevalonic acid, Silk, Fatty acid, AMSilk, Research, Cosmetics, Aviation, Geno, United, Metabolism, Growth, Covestro, Amide, Triglyceride, Solvent, MCFA, Bacteria, CO2, Plastic, HMDA, Synthetic biology, Radar, Ester, Glucose, Amine, Fine chemical, Pharmaceutical industry

Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.

Key Points: 
  • Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.
  • IDTechEx has analyzed over thirty-five different molecules and compounds in their market research report " White Biotechnology 2024-2034 "; here are some of the most interesting molecules whose biomanufacturing development is worth monitoring.
  • Polyamide precursors: one emerging category of biomanufactured molecules are key precursors for polyamides like PA 6 and PA 66.
  • These profiled molecules are just the tip of the iceberg when it comes to the new types of molecules being produced through white biotechnology.

IDTechEx Analysis: Emerging Molecules Produced Through Industrial Biomanufacturing

Retrieved on: 
Tuesday, November 7, 2023
Polymer, SCFA, Nylon, Dicarboxylic acid, PHA, Textile, Polyester, Biomass, Spider, Polyhydroxyalkanoates, Chemical industry, Lubricant, Biotechnology, Digestion, United Nations, Caprolactam, Fermentation, Alcohol, Mevalonic acid, Silk, Fatty acid, AMSilk, Research, Cosmetics, Aviation, Geno, United, Metabolism, Growth, Covestro, Amide, Triglyceride, Solvent, MCFA, Bacteria, CO2, Plastic, HMDA, Synthetic biology, Radar, Ester, Glucose, Amine, Fine chemical, Pharmaceutical industry

Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.

Key Points: 
  • Within this diverse range, an emerging subset of molecules have attracted the interest of numerous companies, both well-funded startups and multinational corporations.
  • IDTechEx has analyzed over thirty-five different molecules and compounds in their market research report " White Biotechnology 2024-2034 "; here are some of the most interesting molecules whose biomanufacturing development is worth monitoring.
  • Polyamide precursors: one emerging category of biomanufactured molecules are key precursors for polyamides like PA 6 and PA 66.
  • These profiled molecules are just the tip of the iceberg when it comes to the new types of molecules being produced through white biotechnology.

Global Organic Chemicals Market Predicted to Reach $286 Billion by 2032, Fueled by Demand in Multiple Industries - ResearchAndMarkets.com

Retrieved on: 
Monday, September 18, 2023
Chemicals, Plastics, Manufacturing, Amine, Food, Petroleum, Drink, Lactic acid, Aluminium, Fertilizer, Alcohol, Cosmetics, Research, Aldehyde, CSR, Government, Wood, Plant, Coal, Solvent, Amide, Animal, Acetic acid, Investment, Organic, Architecture, Citric acid, Growth, Acid, Ether, Organic compound, Ketone, Fine chemical

The global organic chemicals market, which was valued at $153.2 billion in 2022, is expected to experience significant growth, estimated to reach $286.0 billion by 2032, with a remarkable compound annual growth rate (CAGR) of 6.5% from 2023 to 2032.

Key Points: 
  • The global organic chemicals market, which was valued at $153.2 billion in 2022, is expected to experience significant growth, estimated to reach $286.0 billion by 2032, with a remarkable compound annual growth rate (CAGR) of 6.5% from 2023 to 2032.
  • These trends are expected to boost the organic chemicals market for personal care and cosmetics applications.
  • Organic aldehydes, on the other hand, are being used in the manufacturing of industrial chemicals, dyes, and solvents, further increasing demand across various industries.
  • Government initiatives promoting manufacturing in emerging economies like India are also likely to foster further development in the organic chemicals market.

The Global Carbon Capture & Storage (CCS) Market to Surpass $11.8 Billion by 2023 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 15, 2023
Alternative Energy, Energy, Green Technology, Environment, Carbon, CCS, Amine, Nitrogen, Research, Carbon capture, CO2, XLR8, Coal

The "Carbon Capture & Storage (CCS) Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Carbon Capture & Storage (CCS) Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • This report reveals that the overall world revenue for the Carbon Capture & Storage (CCS) market is projected to surpass $11.8 billion in 2023 and predicts strong revenue growth through to 2033, reaching $34.86 billion.
  • The report highlights the revolutionary technological advancements in carbon capture and storage (CCS) that have led to the development of more efficient and cost-effective CO2 capture techniques.
  • The high deployment costs of carbon capture and storage (CCS) are likely to hamper market growth.

Hi-Tech Pharmaceuticals Launches Adderex® XR- Launches the Strongest Focus Aid Ever Developed that Supports Increased Concentration, Focus & Productivity

Retrieved on: 
Monday, August 7, 2023
Central nervous system, Weight management, Marketing, Chocolate, Innovation, Dopamine, Attention, Pharmacy, Amine, Ephedrine, Methylphenidate, Research and development, PEA, Happiness, High tech, Serotonin, XR, Amphetamine, Research

Developed after 20 years of Research and Development by Hi-Tech Adderex® XR utilizes several Hi-Tech proprietary Phenylethylamine compounds –– which are the strongest stimulants and focusing aids available without a prescription!

Key Points: 
  • Developed after 20 years of Research and Development by Hi-Tech Adderex® XR utilizes several Hi-Tech proprietary Phenylethylamine compounds –– which are the strongest stimulants and focusing aids available without a prescription!
  • Normal amounts of PEA produced in the body support healthy energy levels as well as attention and focus, well-being, happiness, and cognitive function.
  • * Adderex® XR | Strongest Focusing Aid without a Prescription — Hi-Tech Pharmaceuticals (hitechpharma.com)
    PEA is a trace amine whose molecular mechanism of action differs from biogenic amines, such as serotonin or dopamine.
  • "Adderex® XR is a next-generation focusing aid and will fill the gap left by other manufacturers lack of production of focusing agents.

Yida Gao and Shima Capital Invest in Blockchain Infrastructure Startup Artela

Retrieved on: 
Friday, July 21, 2023
A&T, Blockchain, Amine, Dispersion, Cryptocurrency, Aspect

LOS ANGELES, July 21, 2023 /PRNewswire/ -- Shima Capital today announces its seed round investment in Artela Network, a blockchain infrastructure startup founded by a team of industry veterans. Other contributors in the round include A&T Capital, Big Brain Holdings, SevenX, Dispersion, Amino, and others.

Key Points: 
  • LOS ANGELES, July 21, 2023 /PRNewswire/ -- Shima Capital today announces its seed round investment in Artela Network, a blockchain infrastructure startup founded by a team of industry veterans.
  • The Artela team is pioneering a unique solution designed to answer the rising need for large-scale, decentralized apps by creating a base-layer blockchain network.
  • The unique architecture of Artela encourages developers to create custom extensions in a modular style directly on the blockchain's base layer.
  • "Artela formally brings to web3 the web2 paradigm of aspect-oriented programming by introducing an extensible blockchain network that allows builders to construct modules and extend modular services to achieve chain-native customization within a single public blockchain network," said Yida Gao, Founder and Managing General Partner at Shima Capital.